Mixed treatment comparisons for atrial fibrillation: Evidence network or bewildering entanglement?

Europace

Volumn 13, Issue 3, 2011, Pages 295-296

  Piccini, Jonathan P ^a   Kong, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DRONEDARONE; FLECAINIDE; PROPAFENONE; SOTALOL;

COMPARATIVE STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SINUS RHYTHM; STROKE; SURVIVAL; UNSPECIFIED SIDE EFFECT;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; EVIDENCE-BASED MEDICINE; FLECAINIDE; HUMANS; PROPAFENONE; SOTALOL; TREATMENT OUTCOME;

EID: 79952119934     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur029     Document Type: Editorial

References (12)

1. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36:1303-9.
2. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010;12: 1360-420.
3. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA III et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines. Circulation 2011;123:104-23.
4. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann J-F. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 2006; 166:719-28.
5. Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 2011;13:329-45.
6. Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2009;54:1089-95.
7. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 2010;21:597-605.
8. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006;27:2846-57. (Pubitemid 44872753)
9. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33. (Pubitemid 35417773)
10. Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL et al. Analysis of stroke in athena: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/ atrial flutter. Circulation, 2009;120:1174-80.
11. Singh D, Cingolani E, Diamond GA, Kaul S. Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium? J Am Coll Cardiol, 2010;55: 1569-76.
12. EMA. EU Standard of Medicinal Product Registration: Clinical Evaluation of Risk/ Benefit - the Role of Comparator Studies, 2004; en-GB/document-library/ Position-statement/2009/12/WC500017660.pdf (10 January 2011, date last accessed).